PFIZER INC Total Long-Term Debt
PFIZER INC (PFE) had Total Long-Term Debt of $4.00 billion as of 2020-12-31, per its 10-K filed 2021-02-25.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified
us-gaap:LongTermDebt · last filed 2021-02-25
- 2020-12-31: Long-term Debt $4.00B.
- 2017-10-01: Long-term Debt $34.50B.
- 2017-07-02: Long-term Debt $34.19B.
- 2017-04-02: Long-term Debt $36.33B.
| Period end | Long-term Debt |
|---|---|
| 2020-12-31 | $4.00B 10-K · filed 2021-02-25 |
| 2017-10-01 | $34.50B 10-Q · filed 2017-11-09 |
| 2017-07-02 | $34.19B 10-Q · filed 2017-08-10 |
| 2017-04-02 | $36.33B 10-Q · filed 2017-05-11 |
| 2016-12-31 | $31.40B 10-K · filed 2017-02-23 |
| 2016-10-02 | $30.44B 10-Q · filed 2016-11-10 |
| 2016-07-03 | $30.46B 10-Q · filed 2016-08-11 |
| 2015-12-31 | $28.82B 10-K · filed 2016-02-29 |
| 2015-09-27 | $29.08B 10-Q · filed 2015-11-05 |
| 2014-12-31 | $31.54B 10-K · filed 2015-02-27 |
| 2014-09-28 | $31.67B 10-Q · filed 2014-11-06 |
| 2014-06-29 | $32.27B 10-Q · filed 2014-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |